http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006526644-A
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-165 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-33 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-167 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 |
filingDate | 2004-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2006-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2006526644-A |
titleOfInvention | Method for treating diseases using HSP-90 inhibitors in combination with enzyme inhibitors |
abstract | The present invention provides a method for treating cancer. The method includes administration of an HSP90 inhibitor and an enzyme inhibitor, the combination administration providing a synergistic effect. In certain embodiments of the invention, a method of treating cancer is provided wherein a subject is treated with a predetermined amount of an HSP90 inhibitor at one stage and a predetermined amount of an enzyme inhibitor at another stage. In another embodiment of the invention, a method of treating cancer is provided in which a subject is first treated with a predetermined amount of an HSP90 inhibitor and then treated with a predetermined amount of an enzyme inhibitor. In another embodiment of the invention, there is provided a method of treating cancer wherein a subject is first treated with a predetermined amount of an enzyme inhibitor and then treated with a predetermined amount of an HSP90 inhibitor. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9808507-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9956244-B2 |
priorityDate | 2003-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 335.